Myelofibrosis (MF) – Page 3 – MPN Research Foundation
Skip to content
MPN Research Foundation
Search for...
Menu
RESEARCH
Research Impact
MPN Challenge™
MPN Roundtable™
Patient-Focused Drug Development
2022 Thrive Initiative
MPN Interferon Initiative
Apply For Research Funding
PATIENTS & CAREGIVERS
MPN Clinical Trials
Patient & Caregiver Stories
Patient & Caregiver Resources
Living with an MPN
Find Support
UNDERSTANDING MPNS
Essential Thrombocythemia (ET)
Polycythemia Vera (PV)
Myelofibrosis (MF)
30 Facts about MPNs
Glossary
SUPPORT US
Make a Donation
Other Ways to Give
Create Your Own Fundraiser
ABOUT MPNRF
Our Mission & History
Board of Directors
Our Team
Scientific Advisory Board
News & Articles
Newsletters
Our Partners
DONATE
JOIN COMMUNITY
Myelofibrosis (MF)
Myelofibrosis (MF)
Selumetinib + Azacitidine
by
MPNRF
March 11, 2021
IMG-7289
by
MPNRF
March 11, 2021
Navitoclax
by
MPNRF
March 11, 2021
Luspatercept
by
MPNRF
March 11, 2021
Pacritinib
by
MPNRF
March 11, 2021
Ruxolitinib vs. Anagrelide
by
MPNRF
March 11, 2021
Ruxolitinib + INCB050465
by
MPNRF
March 11, 2021
Ruxolitinib + Thalidomide
by
MPNRF
March 11, 2021
Ruxolitinib + TGR-1202
by
MPNRF
March 11, 2021
Ruxolitinib + Pomalidomide
by
MPNRF
March 11, 2021
March 11, 2021
« Previous
1
2
3
4
Next »